Identifying and definitional attributes
|Metadata item type:||Indicator|
|Short name:||Indicator 5d- Proportion of patients with a final diagnosis of ischaemic stroke on antithrombotic medications on separation from hospital|
|Registration status:||Australian Commission on Safety and Quality in Health Care, Standardisation pending 09/09/2019|
|Indicator set:||Clinical care standard indicators: acute stroke Australian Commission on Safety and Quality in Health Care, Standard 03/11/2020|
Collection and usage attributes
Both the numerator and the denominator include patients with a final diagnosis of ischaemic stroke.
The numerator requires evidence of prescription and administration of antithrombotics prior to separation. Antithrombotic medications include: oral anticoagulants, such as warfarin, apixaban, rivaroxaban or dabigatran; and antiplatelet agents, such as aspirin, clopidogrel and dipyridamole.
Both the numerator and the denominator exclude patients for whom antithrombotics are contraindicated (where the contraindication is clearly documented). Contraindications may include:
Presented as a percentage.
(Numerator ÷ denominator) x 100
Number of patients with a final diagnosis of ischaemic stroke prescribed and administered antithrombotic medications on separation from hospital.
Number of patients with a final diagnosis of ischaemic stroke separated from hospital.
|Unit of measure:||Episode|
Source and reference attributes
Australian Commission on Safety and Quality in Health Care